Luthi & Co. is rated a Top-Tier IP firm, and the commentary is as follows:

"Luthi & Co specialises in patent litigation, often for multinational companies, particularly from the pharmaceuticals, chemicals, and hi-tech sectors; clients include GlaxoSmithKline, Merck, Research In Motion, and Cisco as well as some of Israel’s largest and longest established companies such as Electra, Israel Aerospace Industries and Tadiran. The team acted for GlaxoSmithKline in a patent dispute relating to Avandia, its diabetes drug, against Unipharm, in the first case for some years to address fundamental issues of patent law before the Supreme Court. Name partner Richard Luthi heads the team, and brings to bear his ‘massive experience and knowledge’. "